It is well-documented that approximately one in every two of patients fail to adhere to therapy when long-term medication is prescribed. Medication non-adherence is a serious problem which affects both patients and healthcare systems alike, contributing to poor disease control, sub-optimal patient outcomes as well as increases in healthcare utilisation and costs.
HealthBeacon plc is the leading Irish digital therapeutics company, and its technology offers a smart solution to some of these issues through the world’s first FDA-cleared Smart Sharps Bin.
Clinically proven to materially enhance adherence to injectable medications, HealthBeacon’s technology supports patients to adhere to prescribed treatments in the home setting.
HealthBeacon’s Injection Care Management System (ICMS) tracks patients’ adherence and persistence to medication schedules through the provision of smart medication reminders and Care Team support calls, safe and sustainable sharps disposal devices, educational materials and driven data analytics.
HealthBeacon were pleased to announce that new peer reviewed evidence demonstrates a 26% improvement in medication adherence for patients using the Company’s ICMS. Further research has shown that 19% more patients persist on treatment one year following initiation when using the HealthBeacon platform to manage their medications.
With improvements in both adherence and persistence to therapy possible, the ICMS represents an innovative approach to optimising patient medication compliance. The results of HealthBeacon’s latest study, published in the prestigious International Journal of Clinical Pharmacy, proves the significant impact the Company’s ICMS can have on medication adherence for patients across a range chronic, autoimmune conditions.
HealthBeacon plc is the leading Irish digital therapeutics company, and its technology offers a smart solution to some of these issues through the world’s first FDA-cleared Smart Sharps Bin HealthBeacon’s growing customer base currently includes Amryt, Novartis, NHS, HSE, Sanofi, Accord Healthcare, Clonmel Healthcare, Teva, Mylan, GSK and AbbVie.